KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Equity Average (2016 - 2025)

Evolent Health (EVH) has 11 years of Equity Average data on record, last reported at $869.1 million in Q3 2025.

  • For Q3 2025, Equity Average fell 16.93% year-over-year to $869.1 million; the TTM value through Sep 2025 reached $869.1 million, down 16.93%, while the annual FY2024 figure was $1.0 billion, 7.36% up from the prior year.
  • Equity Average reached $869.1 million in Q3 2025 per EVH's latest filing, down from $915.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $1.1 billion in Q2 2023 and bottomed at $14.1 million in Q1 2021.
  • Average Equity Average over 5 years is $839.5 million, with a median of $915.8 million recorded in 2025.
  • Peak YoY movement for Equity Average: tumbled 98.42% in 2021, then surged 4540.26% in 2022.
  • A 5-year view of Equity Average shows it stood at $650.6 million in 2021, then soared by 31.85% to $857.8 million in 2022, then increased by 26.13% to $1.1 billion in 2023, then decreased by 5.72% to $1.0 billion in 2024, then fell by 14.79% to $869.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were $869.1 million in Q3 2025, $915.8 million in Q2 2025, and $968.4 million in Q1 2025.